Edymax Lifesciences Private Limited, a active private limited company, was established on 20 December 2017 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290CH2017PTC041809. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sudhir Singal (Director), Sahil Singal (Director). Past directors included Vinay Kumar, Balinder Kumar. It holds ₹2.40 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House Number 3457 Sector-35 D, Chandigarh, Chandigarh, 160036.
U24290CH2017PTC041809
041809
20 December 2017
₹1.00 M
₹0.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Edymax Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Singal | Director | 24 Aug 2018 | Current |
| Sahil Singal | Director | 15 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2018 | Past |
| Pramod Abcsdd | Director | 25 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Edymax Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.74% increase. The company also saw a slight improvement in profitability, with a 9.47% increase in profit. The company's net worth Soared by an impressive increase of 38.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Edymax Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2022 | Karnataka Bank Ltd. | ₹2.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Edymax Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Edymax Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edymax Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Edymax Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Edymax Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
The activity A charge with Karnataka Bank Ltd. of Rs. 2.40 M registered on 11 Jul 2022 with Charge ID 100598289 was modified on 30 Dec 2023. was completed.
Progress on A charge with Karnataka Bank Ltd. amounted to Rs. 2.40 M with Charge ID 100598289 was registered on 11 Jul 2022. was documented.
The activity Sahil Singal was appointed as a Director was appointed as a Director on 15 Jun 2021 & has been associated with this company since 4 years 5 months . was completed.
Progress on Sudhir Singal was appointed as a Director was appointed as a Director on 24 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
The CIN of Edymax Lifesciences Private Limited is U24290CH2017PTC041809.
Edymax Lifesciences Private Limited is headquartered at House Number 3457 Sector-35 D, Chandigarh, Chandigarh, 160036.
Edymax Lifesciences Private Limited was incorporated on 20 December 2017.
The current directors of Edymax Lifesciences Private Limited are
The primary industry of Edymax Lifesciences Private Limited is Trade.
Edymax Lifesciences Private Limited is unlisted.
The authorized capital of Edymax Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Edymax Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX